Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | intercellular adhesion molecule 1 | References | |
Homo sapiens | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1 | References | |
Homo sapiens | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | integrin beta 2 | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Brugia malayi | Integrin beta pat-3 precursor | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Schistosoma japonicum | Integrin beta-3 precursor, putative | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Schistosoma japonicum | Integrin beta-PS precursor, putative | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Schistosoma japonicum | ko:K06464 integrin beta 2, putative | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Echinococcus granulosus | integrin beta 2 | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Loa Loa (eye worm) | integrin beta-2 | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Schistosoma mansoni | integrin beta subunit | Get druggable targets OG5_127959 | All targets in OG5_127959 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | integrin beta 2 | 0.0322 | 0.3791 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.079 | 0.079 |
Brugia malayi | Integrin alpha cytoplasmic region family protein | 0.0112 | 0.0858 | 0.0858 |
Schistosoma mansoni | integrin alpha-ps | 0.0066 | 0.0222 | 0.0787 |
Brugia malayi | Integrin beta pat-3 precursor | 0.0439 | 0.5435 | 0.5435 |
Echinococcus granulosus | geminin | 0.0186 | 0.1901 | 0.5015 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.1901 | 0.6724 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0107 | 0.079 | 0.079 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0107 | 0.079 | 0.079 |
Loa Loa (eye worm) | hypothetical protein | 0.0332 | 0.3941 | 0.3941 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.0261 | 0.0261 |
Echinococcus multilocularis | integrin beta 2 | 0.0322 | 0.3791 | 1 |
Echinococcus multilocularis | integrin alpha ps | 0.0066 | 0.0222 | 0.0587 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0107 | 0.079 | 0.079 |
Loa Loa (eye worm) | kelch domain-containing protein family protein | 0.0069 | 0.0261 | 0.0261 |
Loa Loa (eye worm) | p25-alpha family protein | 0.0766 | 1 | 1 |
Schistosoma mansoni | integrin alpha | 0.0066 | 0.0222 | 0.0787 |
Brugia malayi | Kelch motif family protein | 0.0069 | 0.0261 | 0.0261 |
Loa Loa (eye worm) | integrin alpha pat-2 | 0.0146 | 0.134 | 0.134 |
Loa Loa (eye worm) | integrin beta-2 | 0.0439 | 0.5435 | 0.5435 |
Onchocerca volvulus | TPPP family protein homolog | 0.0766 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0069 | 0.0261 | 0.0261 |
Schistosoma mansoni | hypothetical protein | 0.0073 | 0.0318 | 0.1124 |
Schistosoma mansoni | integrin beta subunit | 0.0253 | 0.2827 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0073 | 0.0318 | 0.0318 |
Echinococcus granulosus | integrin alpha ps | 0.0066 | 0.0222 | 0.0587 |
Brugia malayi | hypothetical protein | 0.0332 | 0.3941 | 0.3941 |
Echinococcus multilocularis | geminin | 0.0186 | 0.1901 | 0.5015 |
Loa Loa (eye worm) | hypothetical protein | 0.0112 | 0.0858 | 0.0858 |
Echinococcus multilocularis | integrin alpha ps | 0.0066 | 0.0222 | 0.0587 |
Loa Loa (eye worm) | hypothetical protein | 0.0073 | 0.0318 | 0.0318 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.1901 | 0.6724 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.0066 | 0.0222 | 0.0222 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.